Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph M Connors

Showing results (91-100 of 302) with videos related to

Pageof 31
Sort By:
BMC Health Services Research|November 2, 2013
Genomic testing to determine drug response: measuring preferences of the public and patients using Discrete Choice Experiment (DCE)Mehdi Najafzadeh, Karissa M Johnston, Stuart J Peacock, et al.
The Lancet. Oncology|November 19, 2013
Brentuximab vedotin combined with ABVD or AVD for patients with newly diagnosed Hodgkin's lymphoma: a phase 1, open-label, dose-escalation studyAnas Younes, Joseph M Connors, Steven I Park, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2016
Secondary Breast Cancer Risk by Radiation Volume in Women With Hodgkin LymphomaJessica L Conway, Joseph M Connors, Scott Tyldesley, et al.
Mechanisms of Ageing and Development|September 4, 2008
Reduced telomere length variation in healthy oldest oldJulius Halaschek-Wiener, Irma Vulto, Dan Fornika, et al.
Leukemia & Lymphoma|March 11, 2017
Nonrandom occurrence of lymphoid cancer types in 140 familiesSamantha J Jones, Jackson Voong, Ruth Thomas, et al.
Blood|March 27, 2010
Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcomeChristian Steidl, Adele Telenius, Sohrab P Shah, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 20, 2016
Quantifying Benefit of Autologous Transplantation for Relapsed Follicular Lymphoma Patients via Instrumental Variable AnalysisDanielle H Oh, Haocheng Li, Qiuli Duan, et al.
Leukemia & Lymphoma|May 27, 2015
Impact of time from diagnosis to initiation of curative chemotherapy on survival of patients with diffuse large B-cell lymphomaKevin Hay, Benny Lee, Ozge Goktepe, et al.
The Oncologist|February 27, 2014
Effect of place of residence and treatment on survival outcomes in patients with diffuse large B-cell lymphoma in British ColumbiaBenny Lee, Ozge Goktepe, Kevin Hay, et al.
International Journal of Cancer|October 16, 2007
Hepatitis C virus and risk of non-Hodgkin lymphoma in British Columbia, CanadaJohn J Spinelli, Agnes S Lai, Mel Krajden, et al.
Pageof 31

Showing results (91-100 of 302) with videos related to

Sort By:
Pageof 31
BMC Health Services Research|November 2, 2013
Genomic testing to determine drug response: measuring preferences of the public and patients using Discrete Choice Experiment (DCE)Mehdi Najafzadeh, Karissa M Johnston, Stuart J Peacock, et al.
The Lancet. Oncology|November 19, 2013
Brentuximab vedotin combined with ABVD or AVD for patients with newly diagnosed Hodgkin's lymphoma: a phase 1, open-label, dose-escalation studyAnas Younes, Joseph M Connors, Steven I Park, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2016
Secondary Breast Cancer Risk by Radiation Volume in Women With Hodgkin LymphomaJessica L Conway, Joseph M Connors, Scott Tyldesley, et al.
Mechanisms of Ageing and Development|September 4, 2008
Reduced telomere length variation in healthy oldest oldJulius Halaschek-Wiener, Irma Vulto, Dan Fornika, et al.
Leukemia & Lymphoma|March 11, 2017
Nonrandom occurrence of lymphoid cancer types in 140 familiesSamantha J Jones, Jackson Voong, Ruth Thomas, et al.
Blood|March 27, 2010
Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcomeChristian Steidl, Adele Telenius, Sohrab P Shah, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 20, 2016
Quantifying Benefit of Autologous Transplantation for Relapsed Follicular Lymphoma Patients via Instrumental Variable AnalysisDanielle H Oh, Haocheng Li, Qiuli Duan, et al.
Leukemia & Lymphoma|May 27, 2015
Impact of time from diagnosis to initiation of curative chemotherapy on survival of patients with diffuse large B-cell lymphomaKevin Hay, Benny Lee, Ozge Goktepe, et al.
The Oncologist|February 27, 2014
Effect of place of residence and treatment on survival outcomes in patients with diffuse large B-cell lymphoma in British ColumbiaBenny Lee, Ozge Goktepe, Kevin Hay, et al.
International Journal of Cancer|October 16, 2007
Hepatitis C virus and risk of non-Hodgkin lymphoma in British Columbia, CanadaJohn J Spinelli, Agnes S Lai, Mel Krajden, et al.
Pageof 31